Breast cancer treatment
131 – 140 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
- Contribution to journal › Article
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
- Contribution to journal › Article
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
- Contribution to journal › Article
-
Mark
Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype
- Contribution to journal › Article
-
Mark
Statin use, HMGCR expression, and breast cancer survival – The Malmö Diet and Cancer Study
- Contribution to journal › Article
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
- Contribution to journal › Article
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
(2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18
- Contribution to journal › Published meeting abstract
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
- Contribution to journal › Article
